These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6656169)

  • 41. [Treatment of pollinosis in children by specific peroral hyposensitization].
    Reviakina VA; Balabolkin II; Vakhrameeva SI; Botvin'eva VV; Ivanov VG
    Pediatriia; 1988; (6):80-2. PubMed ID: 3186412
    [No Abstract]   [Full Text] [Related]  

  • 42. The IgG subclasses of antibodies to grass pollen allergens produced in hay fever patients during hyposensitization.
    Devey ME; Wilson DV; Wheeler AW
    Clin Allergy; 1976 May; 6(3):227-36. PubMed ID: 939035
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Depression of grass pollen-induced lymphocyte transformation by serum from hyposensitized patients.
    Romagnani S; Biliotti G; Ricci M
    Clin Exp Immunol; 1975 Jan; 19(1):83-91. PubMed ID: 1204240
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Childhood asthma: clinical and immunological changes over a decade.
    Hill DJ; Hosking CS; Shelton MJ; Turner MW
    Clin Exp Allergy; 1991 May; 21(3):343-9. PubMed ID: 1863897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Contact sensitivity to aluminium in a patient hyposensitized with aluminium precipitated grass pollen.
    Clemmensen O; Knudsen HE
    Contact Dermatitis; 1980 Aug; 6(5):305-8. PubMed ID: 7418388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predictive value of serum IgE levels during rush hyposensitization.
    Kjellman NI; Lanner A; Roth A
    Clin Allergy; 1977 Sep; 7(5):465-71. PubMed ID: 589780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral immunotherapy with grass pollen in enterosoluble capsules. A prospective study of the clinical and immunological response.
    Urbanek R; Bürgelin KH; Kahle S; Kuhn W; Wahn U
    Eur J Pediatr; 1990 May; 149(8):545-50. PubMed ID: 1693335
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyposensitization in childhood hay fever. A comparison of refined and whole timothy extracts.
    Kjellman NI; Lanner A
    Allergy; 1980 Jun; 35(4):323-34. PubMed ID: 6108724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Failure of hyposensitisation in treatment of children with grass-pollen asthma.
    Hill DJ; Hosking CS; Shelton MJ; Turner MW
    Br Med J (Clin Res Ed); 1982 Jan; 284(6312):306-9. PubMed ID: 6800440
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Grass pollen hyposensitization versus placebo therapy. II. Immunotherapy-induced changes in serum IgE and IgG levels.
    Weyer A; Doinel C; Debbia M; L'Heritier C; Rivat L; Le Mao J; Hirth C; David B
    Allergy; 1981 Jul; 36(5):319-28. PubMed ID: 7032342
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparision of a glutaraldehyde-modified pollen--tyrosine adsorbate with an alum-precipitated pollen vaccine in the treatment of hay fever.
    Symington IS; O'Neill D; Kerr JW
    Clin Allergy; 1977 Mar; 7(2):189-94. PubMed ID: 872364
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparative study of an aqueous grass pollen extract and glutaraldehyde-treated grass pollen-tyrosine adsorbate in the treatment of pollenosis.
    Verstraeten JM; Wheeler AW
    Clin Allergy; 1978 Sep; 8(5):435-43. PubMed ID: 101317
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of hay fever in general practice by hyposensitization, using 'Pollinex'.
    Purser JR
    Curr Med Res Opin; 1976; 4(2):124-7. PubMed ID: 1277879
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A trial of hyposensitization in 1974/5 in the treatment of hay fever using glutaraldehyde-pollen-tyrosine adsorbate.
    Miller AC
    Clin Allergy; 1976 Nov; 6(6):557-61. PubMed ID: 827394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Heredity and comparative effectiveness of several methods of specific hyposensitization in children with pollinosis].
    Salimov EI; L'vovich AM
    Pediatriia; 1989; (6):111-2. PubMed ID: 2762048
    [No Abstract]   [Full Text] [Related]  

  • 56. Seasonal changes in serum and nassal IgE concentrations.
    Yunginger JW; Gleich GJ
    J Allergy Clin Immunol; 1973 Mar; 51(3):174-86. PubMed ID: 4687913
    [No Abstract]   [Full Text] [Related]  

  • 57. A metabolizable adjuvant: clinical trial of grass pollen-tyrosine adsorbate.
    Miller AC; Tees EC
    Clin Allergy; 1974 Mar; 4(1):49-55. PubMed ID: 4824572
    [No Abstract]   [Full Text] [Related]  

  • 58. [Immunotherapy (hypo-/desensitization) in allergic diseases (author's transl)].
    Urbanek R
    Monatsschr Kinderheilkd; 1981 Jan; 129(1):13-7. PubMed ID: 6116174
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [New therapeutic efforts in hyposensitization].
    Immun Infekt; 1991 Dec; 19(6):V-VI. PubMed ID: 1802828
    [No Abstract]   [Full Text] [Related]  

  • 60. Pollen hyposensitization: interval between maintenance injections.
    Freedman SS; Boyd GK
    J Asthma Res; 1967 Dec; 5(2):133-8. PubMed ID: 6079836
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.